Alphatec entered into a definitive securities purchase agreement to raise ~US $18.9MM in a private placement of common stock, Series A Convertible Preferred Stock and warrants exercisable for common stock, expected to close by March 28.
Net proceeds will support general corporate/working capital purposes, e.g. surgeon user expansion and launch of products such as Arsenal Deformity™, Battalion™ Lateral and XYcor® Expandable Interbody systems, etc.
Alphatec entered into a definitive securities purchase agreement to raise ~US $18.9MM in a private placement of common stock, Series A Convertible Preferred Stock and warrants exercisable for common stock, expected to close by March 28.
Net proceeds will support general corporate/working capital purposes, e.g. surgeon user...
Alphatec entered into a definitive securities purchase agreement to raise ~US $18.9MM in a private placement of common stock, Series A Convertible Preferred Stock and warrants exercisable for common stock, expected to close by March 28.
Net proceeds will support general corporate/working capital purposes, e.g. surgeon user expansion and launch of products such as Arsenal Deformity™, Battalion™ Lateral and XYcor® Expandable Interbody systems, etc.
Copy to clipboard 
